HPGD and urinary bladder carcinoma: Studies have shown that the absence or reduction of 15-PGDH promotes the development of tumors in breast cancer, medullary thyroid carcinoma, PCa, and bladder cancer [105,106,107,108], thus supporting a tumor-suppressor role for 15-PGDH in cancer.